Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530919 · ClinicalTrials.gov registry record
Minimally Invasive Radioguided Parathyroidectomy
A clinical trial of Primary Hyperparathyroidism, sponsored by University of Louisville.
- Completed
- Registry status
- 856
- Enrollment target
- 1
- Study location
NCT01530919: Completed study of Primary Hyperparathyroidism, sponsored by University of Louisville.
NCT01530919 is a study of Primary Hyperparathyroidism that has completed, run by University of Louisville. The registered enrollment target is 856 participants, above the 630-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01530919, a study of Primary Hyperparathyroidism, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 856 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this research study is to evaluate the effectiveness of a minimally invasive surgical approach to removing parathyroid gland(s). The researchers are also interested in analyzing abnormal parathyroid tissue for changes in genes and proteins that may contribute to overactive parathyroid gland(s).
Conditions Studied
Interventions
- PROCEDURE Minimally invasive radioguided parathyroidectomy
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 856 participants |
| Start Date | 1998-09 |
| Est. Completion | 2017-04 |
What the finished NCT01530919 record still lists
NCT01530919 is an observational study that tracks outcomes without assigning an intervention. The registered 856 participants enrollment target is mid-sized for trials with a published cap, above the 630-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (36% higher).
The record links to 1 condition, with Primary Hyperparathyroidism appearing as the primary indexed condition, and to 1 intervention - of which Minimally invasive radioguided parathyroidectomy is the first listed.
NCT01530919 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT01530919 about?
NCT01530919 is a clinical study titled "Minimally Invasive Radioguided Parathyroidectomy". The main purpose of this research study is to evaluate the effectiveness of a minimally invasive surgical approach to removing parathyroid gland(s). The researchers are also interested in analyzing abnormal parathyroid tissue for changes in genes and proteins that may contribute to overactive parath...
What is the current status of trial NCT01530919?
This trial is currently completed. The enrollment target is 856 participants. The study started on 1998-09. Estimated completion is 2017-04.
What conditions does trial NCT01530919 study?
This clinical trial studies the following conditions: Primary Hyperparathyroidism.
What interventions are being tested in trial NCT01530919?
The interventions under investigation include: Minimally invasive radioguided parathyroidectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01530919?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01530919 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Hyperparathyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
RECRUITING · Phase 4
-
Parathyroid Tumor Clonal Status
RECRUITING
-
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
RECRUITING
-
Natural History Study of Parathyroid Disorders
RECRUITING
-
Glycemic Control, Type II Diabetes, Parathyroidectomy
ACTIVE NOT RECRUITING
-
Object Assessment of Improvement in Non-Specific Symptoms After Parathyroidectomy for Primary Hyperparathyroidism
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06231485 · 856 participants · NA
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
- NCT05108896 · 855 participants · NA
Aspiration in Acute Respiratory Failure Survivors 2
- NCT07005102 · 854 participants · Phase 2
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- NCT07290491 · 854 participants · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia